long intergenic non-protein coding RNA 1972Genealiases: []
Q-omics provides the consensus-scored LINC01972 profile across patient tissues and cancer cell-line models. LINC01972 expression is associated with patient survival in 17 of 34 cancer types, with the highest sampling consensus in ACC. Among the 18 cancer types available for tumor–normal comparison, LINC01972 is differentially expressed in 9, with the highest sampling consensus in THCA. Additionally, LINC01972 RNA expression shows 6,106 significant pathway-activity associations, with the highest sampling consensus in STAD. Together, these results highlight ACC, THCA, and STAD as cancer lineages where LINC01972 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for LINC01972 — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes LINC01972 survival associations across molecular data types. LINC01972 RNA expression shows survival associations in the most cancer types (17). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible LINC01972 RNA expression–survival associations across cancer types. High LINC01972 expression shows unfavorable associations in ACC, KIRC, STAD and UVM, but favorable associations in BLCA and MESO. The ACC Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p < 0.001). Together, the overview and detailed table identify ACC as the clearest survival context for LINC01972 RNA expression.
This table summarizes LINC01972 tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 9. The strongest signals are observed in THCA for RNA.
This table ranks reproducible tumor–normal expression differences for LINC01972. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. LINC01972 shows lower tumor expression in KICH and KIRP and higher tumor expression in THCA, HNSC, BRCA and LUSC. The THCA box plot shows higher LINC01972 RNA expression in tumor versus normal tissue (log2 FC = +0.172, t-test p = .003).
This table shows molecular features associated with LINC01972 in patient tissues and cancer cell lines. In patient samples, LINC01972 shows the broadest associations at the RNA and protein expression levels, with STAD recurring as the lineage with the largest associated feature set.
